P.KurzE.MishraA.et al (2018)
What Did Not Change on July 23 No approved indication or dosing label exists The committee did not create an approved indication for ulcerative colitis, tendon injury, ligament injury, muscle recovery, joint pain, gut symptoms, or general wellness
( 8 ) Alternatively, methylcobalamin may have a higher retention rate than cyanocobalamin and can be obtained through food sources such as fish, eggs, meat, and milk

WADA Prohibition The World Anti-Doping Agency classifies multiple components as prohibited substances: BPC-157: Listed under Section S0 (Non-Approved Substances), prohibited at all times TB-500: Listed under S2: Peptide Hormones, Growth Factors, prohibited at all times GHK-Cu: Not specifically prohibited but peptide combinations generally scrutinized KPV: Not explicitly listed but could fall under similar chemical structure provisions No Therapeutic Use Exemptions (TUEs) available for any prohibited components Combined formulations would fall under multiple prohibited categories Detection methods developed for BPC-157 (up to 4 days) and TB-500 WADAs prohibition reflects the lack of regulatory approval from health authorities worldwide for these peptides and concerns about tissue-regenerative and performance-enhancing properties
Protein kinase C controls lysosome biogenesis independently of mTORC1
In the NEJM 2023 Phase 2 trial (Jastreboff et al.), the 12 mg weekly dose group achieved roughly 17.5 percent mean weight reduction by week 24, compared to roughly 1.6 percent in placebo